Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 110,000 shares at $12.29 ($1.4M) on 2025-04-21, disclosed to the SEC on 2025-04-22.
Scheduled sale ($1.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.29 | 14,656 | $180K | 13.2% |
| 2 | $12.29 | 14,656 | $180K | 13.2% |
| 3 | $12.43 | 40,344 | $501K | 36.8% |
| 4 | $12.43 | 40,344 | $501K | 36.8% |
| Total | $12.39 avg | 110,000 | $1.4M | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |
| CLVT | BUY | 2025-03-05 | $508K | — | Filing → |